US FDA Exploring Virtual Advisory Cmtes.; Might Sponsors Want To Wait For In-Person Meetings?

 
• By Derrick Gingery

Likelihood of webcast-only advisory committee meetings may depend on the extent of the coronavirus outbreak, Office of New Drugs Director Peter Stein tells the Pink Sheet in an interview.

FDA Advisory Committee Feature image
The FDA may have to conduct virtual advisory committee meetings for some applications should coronavirus restrictions on public gatherings continue. • Source: Illustration

More from US FDA Performance Tracker

More from Regulatory Trackers